Advertisement
Screener

Echo Therapeutics, Inc. Accounts Receivable

Echo Therapeutics, Inc. Accounts Receivable

Echo Therapeutics, Inc. had Accounts Receivable of $3.55 thousand as of 2012-06-30, per its 10-Q filed 2012-08-09.

Discontinued › Balance Sheet › Assets › Assets, Current

us-gaap:AccountsReceivableNetCurrent · last filed 2013-03-18

  • 2012-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $3.55K.
  • 2011-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $37.06K.
  • 2011-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $40.68K.
  • 2011-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $37.06K.
Period endAccounts Receivable, after Allowance for Credit Loss, Current
2012-06-30$3.55K
10-Q · filed 2012-08-09
2011-12-31$37.06K
10-K · filed 2013-03-18
2011-09-30$40.68K
10-Q · filed 2011-11-08
2011-06-30$37.06K
10-Q · filed 2011-08-12
2010-12-31$141.49K
10-K · filed 2012-03-15